About Quest Lab
Quest Lab is a company based in Dhar (India) founded in 1994. It operates as a Reseller / Distribution and Contract Manufacturing. The company has 64 employees. Quest Lab offers products and services including Chlorpheniramine Maleate Tablets IP 4 mg, Metformin Hydrochloride Tablets IP 500 mg, and Povidone-Iodine Ointment U.S.P..
- Headquarter Dhar, India
- Employees 64
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website questlabltd.com
- Legal Name Quest Laboratories Ltd.
- Annual Revenue₹108 Cr
FY 2025 · +31% YoY
- Net Profit₹13.57 Cr
FY 2025 · 13% margin
- EBITDA₹20.23 Cr
FY 2025 · 19% margin
- Employee Count64
Associated legal entities of Quest Lab
Quest Lab operates through Quest Laboratories Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Quest Laboratories Limited CIN U24232MP1998PLC012850 | Active | 01 Jun 1998 | Dhar, Madhya Pradesh | ₹108 Cr | 64 | 9 | View details |
Products & Services of Quest Lab
Quest Lab offers a comprehensive portfolio of products and services, including Chlorpheniramine Maleate Tablets IP 4 mg, Metformin Hydrochloride Tablets IP 500 mg, and Povidone-Iodine Ointment U.S.P..
Tablets are provided for allergy symptom relief purposes.
Tablets are offered for managing type 2 diabetes.
Ointment is supplied for antiseptic and wound treatment.
Board of directors of Quest Laboratories Limited (Quest Lab)
Quest Laboratories Limited is the primary company behind Quest Lab. The board of Quest Laboratories Limited currently have 7 directors; the longest-serving is Tejaswini Chouhan, appointed in 2021. 12 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tejaswini Chouhan DIN 09088283 | Whole-time director | 05 Mar 2021 | 5 yrs 7 mo | Quest Laboratories Limited |
| Anil Kumar Sabarwal DIN 00646133 | Managing Director | 21 Feb 2022 | 4 yrs 7 mo | Quest Laboratories Limited |
| Amit Ramesh Chandak DIN 09419479 | Director | 10 Jan 2024 | 2 yrs 9 mo | Quest Laboratories Limited |
| Basant Lal Menghwani DIN 10459081 | Director | 10 Jan 2024 | 2 yrs 9 mo | Quest Laboratories Limited |
| Gautam Chand Kothari DIN 00115063 | Director | 10 Jan 2024 | 2 yrs 9 mo | Quest Laboratories Limited |
| Umendra Singh DIN 10686009 | Whole-time director | 01 Jul 2024 | 2 yrs 3 mo | Quest Laboratories Limited |
| Vinayak Sabarwal DIN 09591941 | Whole-time director | 01 Jul 2024 | 2 yrs 3 mo | Quest Laboratories Limited |
People of Quest Lab
1 people are tracked at Quest Lab (1 in leadership); the tracked headcount is 64.
| Name | Role | Group |
|---|---|---|
| Owner & Managing Director | Leadership |
Complete people profiles for Quest Lab
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Quest Lab
Quest Lab is a publicly listed company on the NSE with ticker symbol QUESTLAB in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date23 May 2024
- Listed onNSE: QUESTLAB
- Listed entityQuest Laboratories Ltd.
- Exchange sectorHealth technology
- ISININE0TNW01017
- Share price₹94.25 (-3.03% on the day) · 2026-10-14
- Market capitalisation₹164 Cr
- Price to earnings10.3
- EPS (diluted, trailing year)₹9.16
- Volume (last session)2,400
Financials of Quest Lab
Figures of Quest Laboratories Limited, the primary company behind Quest Lab, for FY 2025. Revenue was ₹108 Cr (+31% year on year). Net profit was ₹13.57 Cr (13% margin). EBITDA was ₹20.23 Cr (19% margin). Revenue has grown at a compounded annual rate of +22% over three years and +33% over five years.
- ₹108 CrRevenue · FY 2025 · +31% YoY
- ₹13.57 CrNet profit · 13% margin
- ₹20.23 CrEBITDA · 19% margin
- ₹16.39 CrPaid-up capital
- 64Employees (provident fund records)
- +22%Revenue CAGR, 3 years
- +33%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | ₹112 Cr | ₹14.9 Cr | ₹18.5 Cr |
| 2024 | ₹104 Cr | ₹13.7 Cr | ₹16.2 Cr |
| 2023 | ₹82.6 Cr | ₹10.1 Cr | ₹15.7 Cr |
| 2022 | ₹61.6 Cr | ₹5.0 Cr | ₹7.8 Cr |
| 2021 | ₹59.5 Cr | ₹4.1 Cr | ₹6.5 Cr |
Balance sheet, profit and loss, cash flow and ratios of Quest Laboratories Limited are on its company page.
Detailed financial statements for Quest Lab
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Latest news on Quest Lab
Complete news archive for Quest Lab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Quest Lab
10 companies that operate in the same segment as Quest Lab (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Quest Lab
Quest Lab was founded in 1994.
Quest Lab is headquartered in Dhar, India. It is registered at Dhar, Madhya Pradesh, India.
Quest Lab has 64 employees.
The primary company behind Quest Lab, Quest Laboratories Limited, reported revenue of ₹108 Cr for FY 2025, up 31% year on year.
Quest Laboratories Ltd. is involved in the production of pharmaceutical formulations, including generics, branded generics, and complex drugs like sustain release. Operations are focused on institutional supplies, domestic markets, and exports within the healthcare sector. A wide range of products, such as tablets, syrups, suspensions, powders, and ointments, are manufactured. Solutions are provided for chronic and acute therapies with a commitment to cost-effective, high-quality healthcare manufacturing.
Quest Lab offers Chlorpheniramine Maleate Tablets IP 4 mg, Metformin Hydrochloride Tablets IP 500 mg, and Povidone-Iodine Ointment U.S.P..
Yes, Quest Lab is publicly traded on NSE under the ticker symbol QUESTLAB.
Quest Lab operates through Quest Laboratories Limited.
The legal entities of Quest Lab currently have 9 directors, including Anil Kumar Sabarwal, Tejaswini Chouhan, Amit Ramesh Chandak and others.